<DOC>
	<DOCNO>NCT01299987</DOCNO>
	<brief_summary>This prospective , multicentric single arm phase II study base protocol international TARGIT-A study . The purpose investigate efficacy single intraoperative radiotherapy treatment within elderly low risk patient ( ≥ 70 year , cT1 , cN0 , cM0 , invasive-ductal ) follow WBRT risk factor present . In presence risk factor postoperative WBRT add complete radiotherapeutic treatment accord international guideline .</brief_summary>
	<brief_title>Prospective Phase II Study Intraoperative Radiotherapy ( IORT ) Elderly Patients With Small Breast Cancer</brief_title>
	<detailed_description>Patients ≥ 70 year small , low-risk breast cancer operate irradiated show local relapse rate around 4 % 4 year . With adjuvant whole breast radiotherapy ( WBRT ) local relapse rate drop 1 % 4 year Tamoxifen ( Hughes et al 2004 ) . It demonstrate ( Polgar et al . 2007 , Vaidya et al . 2010 ) efficacy radiation tumor bed select group non-inferior WBRT . The TARGIT E study confirm efficacy single dose intraoperative radiotherapy ( IORT ) well select group elderly patient small breast cancer absence risk factor . In presence risk factor postoperative WBRT add complete radiotherapeutic treatment accord international guideline . Endpoints local relapse rate ( within 2 cm tumor bed ) , ipsilateral relapse , cancer-specific overall survival contralateral breast cancer well documentation quality life cosmetic outcome . The expected local relapse rate 0.5/1/1.5 % 2.5/5/7.5 year , respectively . Discontinuation trial schedule rate local relapse rate rise 3/4/6 % 2.5/5/7.5 year . Power calculation result 265 patient calculated loss follow-up 20 % , alpha 0.05 beta 0.1 . Only center access Intrabeam® system ( Carl Zeiss ) recruit patient trial .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Breast Diseases</mesh_term>
	<mesh_term>Neoplasm Recurrence , Local</mesh_term>
	<criteria>cT1c cN0 cM0 ≥ 70 year old invasiveductal histology compliance inform consent extensive intraductal component ( EIC ) multifocality /centricity lymph vessel invasion ( L1 ) clinical sign distant metastasis clinically suspicious lymph node histology &lt; 70 year old miss informed consent noncompliance bilateral breast cancer time diagnosis know BRACA 1/2 mutation ( genetic testing require )</criteria>
	<gender>Female</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Keywords provide University Hospital Mannheim :</keyword>
	<keyword>Intraoperative Radiotherapy</keyword>
	<keyword>Early Breast Cancer</keyword>
	<keyword>Elderly Patients</keyword>
</DOC>